Company news

CelLBxHealth plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Issue of share options

November 28, 2016

Result of GM

November 24, 2016

Barts Research Supports Potential Use of Parsortix

November 4, 2016

Notice of GM

November 1, 2016

Director's share purchase

October 27, 2016

Research published in Clinical Chemistry

September 30, 2016

Annual Report and Accounts and Notice of AGM

September 9, 2016

MD Anderson Cancer Center poster presentation

August 4, 2016

Edison issues ADR update on Angle

August 2, 2016

Use of Parsortix in GANNET53 drug trial

July 28, 2016

Initiation of 200 patient US ovarian cancer study

July 27, 2016

Initiation of European ovarian cancer study

July 19, 2016

Parsortix gaining traction at EACR Conference

July 15, 2016

Edison issues research update on Angle

May 27, 2016

Cancer Research UK Contract

May 25, 2016

New publications utilising Parsortix

April 29, 2016

Parsortix potential in metastatic breast cancer

April 18, 2016

Parsortix potential for prostate cancer detection

March 21, 2016

European patent grant for Parsortix

March 9, 2016

Notice of Interim Results

January 27, 2016

UKE publishes evaluation of Parsortix

January 25, 2016

Completion of Geomerics Transaction

December 22, 2015

Parsortix first commercial sales

December 15, 2015

Change of FTSE Industry Classification Benchmark

December 10, 2015

Lung Cancer Research Publication

November 17, 2015

Patent Grant

October 14, 2015

Ovarian cancer results

September 28, 2015

Prostrate cancer study published PLOS ONE Journal

September 24, 2015

Breast cancer results presented at cdx conference

September 9, 2015

Issue of Equity and Total Voting Rights

August 26, 2015

Final Results

July 23, 2015

Notification of Preliminary Results

July 20, 2015

Appointment Of Scientific Adviser

July 8, 2015

Barts Prostate Cancer Update

June 11, 2015

Appointment of Scientific Adviser

June 3, 2015

New Patent Grants

May 26, 2015

Ovarian Cancer Update

April 21, 2015

Sidney Kimmel Cancer Centre

April 20, 2015

Offer to Shareholders

March 4, 2015

MD Anderson Collaboration

February 16, 2015

"Unprecedented Specificity" in Ovarian Cancer

January 27, 2015

Corporate Collaboration

January 23, 2015

Further information re Director's share transfer

January 21, 2015

Notification of Interim Results

January 19, 2015

Cancer Research Manchester Institute Publication

December 15, 2014

Issue of Share Options

November 10, 2014

ADR programme

October 31, 2014

Director's Share Transfer

October 21, 2014

Collaboration with Barts Cancer Institute

October 17, 2014

Collaboration with Thomas Jefferson University

September 30, 2014

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 30 decks. Every deck is listed under its year.